FMP

FMP

Enter

ELDN - Eledon Pharmaceutica...

Financial Summary of Eledon Pharmaceuticals, Inc.(ELDN), Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medici

photo-url-https://financialmodelingprep.com/image-stock/ELDN.png

Eledon Pharmaceuticals, Inc.

ELDN

NASDAQ

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

2.16 USD

0.14 (6.48%)

About

ceo

Dr. David-Alexandre C. Gros M.D., Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://eledon.com

exchange

NASDAQ

Description

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2...

CIK

0001404281

ISIN

US28617K1016

CUSIP

28617K101

Address

19900 MacArthur Boulevard

Phone

949 238 8090

Country

US

Employee

20

IPO Date

Sep 17, 2014

Summary

CIK

0001404281

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

28617K101

ISIN

US28617K1016

Country

US

Price

2.16

Beta

0.93

Volume Avg.

89.28k

Market Cap

52.27M

Shares

-

52-Week

1.07-2.95

DCF

0.17

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.32

P/B

-

Website

https://eledon.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ELDN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep